Onapsis Releases New Service that Helps Organizations Frame

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Onapsis Releases New Service that Helps Organizations Frame the Business Risk of an SAP Cyberattack

BOSTON, Mass., Jan. 12, 2016 (GLOBE NEWSWIRE) -- via PRWEB - Onapsis , the global experts in business-critical application security, today released the Onapsis Business Risk Illustration service. This complimentary service analyzes the business risk of an SAP cyberattack and the impact that it would have on an organization.

"We're finding there are multiple groups within an organization that are tasked with the orchestration of SAP for business and who overlook cybersecurity. Infosec, SAP Basis Teams, as well Application security groups all have different responsibilities that are not aligned to an overall SAP security strategy. Between keeping the business running, securing the environment, and managing governance and compliance, organizations also need to operationalize SAP cybersecurity. Our Business Risk Illustration analyzes an organization's SAP risk posture, and helps teams operationalize best-in-class SAP cybersecurity programs," said Jake Simpson, executive vice president of worldwide sales, Onapsis.

The Onapsis Business Risk Illustration service is performed on-site by Onapsis SAP cybersecurity experts with the goal of understanding an organization's SAP landscape, the correlation between technical vulnerabilities and business risk, as well as compromises that have been made and the potential impact to the organization.

The results of the Onapsis Business Risk Illustration will allow an organization to map out their economic, financial, compliance and lost data risks to determine the best course of action. This analysis helps to effectively show the impact of vulnerabilities that can be used to compromise key data and business processes, and provides recommendations for how to prioritize and implement cross-functional remediation efforts over time.

"Thousands of SAP systems across the globe are subject to cyberattacks and information security teams are largely oblivious to the continuous tide of vulnerabilities in SAP systems. The business implications due to a compromised system are real and are often difficult to quantify. The Business Risk Illustration is the best way for security teams, as well as C-level executives to understand the risk exposure tied to the business impact," said Juan Perez-Etchegoyen, CTO, Onapsis. "The important thing to note is that most attacks on SAP systems go unnoticed for months– if ever – and that in most cases, the impact of an SAP breach is analyzed after it is too late to respond efficiently, or to contain the compromise."

Key Deliverables of the Onapsis Business Risk Illustration Include:

  • A listing of SAP cyberattacks and the impact that it can have on your organization.
  • Detailed summary report of all existing vulnerabilities found in scanned SAP systems.
  • Breakdown of how each discovery can be leveraged by an attacker.
  • Outline of potential impacts on your business when a weakness is exploited.
  • SAP cybersecurity program and remediation recommendations.

For more information, or to schedule a Business Risk Illustration please visit: https://www.onapsis.com/services/business-risk-illustration .

On Thursday, March 10, 2016 Onapsis will be hosting a webcast to further discuss this service and recent findings. To register, please visit: https://www.onapsis.com/news-and-events/webca...Is-webcast .

About Onapsis Onapsis provides the most comprehensive solutions for securing SAP and Oracle business-critical applications. As the leading experts in SAP and Oracle cybersecurity, Onapsis enables security and audit teams to have visibility, confidence and control of advanced threats, cyber risks and compliance gaps affecting their enterprise applications. Headquartered in Boston, Onapsis serves over 180 Global 2000 customers, including 10 top retailers, 20 top energy firms and 20 top manufacturers. Onapsis' solutions are also the de-facto standard for leading consulting and audit firms such as Accenture, IBM, Deloitte, E&Y, KPMG and PwC.

Onapsis solutions include the Onapsis Security Platform (OSP), which is the most widely used SAP-certified cybersecurity solution in the market. Unlike generic security products, Onapsis' context-aware solutions deliver preventative vulnerability and compliance controls, as well as real-time detection and incident response capabilities to reduce risks affecting critical business processes and data. Through open interfaces, the platform can be integrated with leading SIEM, GRC and network security products, seamlessly incorporating enterprise applications into existing vulnerability, risk and incident response management programs.

These solutions are powered by the Onapsis Research Labs™, which continuously provide leading intelligence on security threats affecting SAP and Oracle enterprise applications. Experts of the Onapsis Research Labs were the first to lecture on SAP cyberattacks and have uncovered and helped fix hundreds of security vulnerabilities to date affecting SAP Business Suite, SAP HANA, SAP Cloud and SAP Mobile applications, as well as Oracle JD Edwards and Oracle E-Business Suite platforms.

For more information, please visit http://www.onapsis.com , or connect with us on Twitter , Google+ , or LinkedIn . Onapsis and Onapsis Research Labs are registered trademarks of Onapsis, Inc. All other company or product names may be the registered trademarks of their respective owners.

This article was originally distributed on PRWeb. For the original version including any supplementary images or video, visit http://www.prweb.com/releases/2016/01/prweb13159461.htm

Kesselring Communications Leslie Kesselring +1 503-358-1012

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 363

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 387

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 544

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
Bloomberg, HKEX Expand Offshore RMB Bond Indices

Updated Category News Views 109

A Move to Elevate Dim Sum Bonds If you're wondering what's cooking in the bond market arena, Bloomberg and HKEX just turned up the heat with a new family of RMB bond indices. These aren't just any run-of-the-mill indices; they're targeting the offshore RMB market, affectionately called the Dim Sum bond market. For those of us grizzled vets in the trading world, this is...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 305

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Thunes Boosts Bhutan Remittances with Instant Payments

Updated Category News Views 161

Thunes' Network Expands to Bhutan: A Game Changer I'll say one thing clear—Thunes isn't messing around. They've just opened the gates for real-time payouts to Bhutan, and it's going to be a game-changer for those living abroad who want to send money back home. Look, for years, Non-Resident Bhutanese have been diving into hoops just to get their bucks across borders....

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 380

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 411

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 174

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 277

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading

Top 5 Most Recently Viewed Articles

Exciting Breakthroughs in Lung Cancer Treatment with Reqorsa

Updated Category News Views 182

Innovative Advances in Lung Cancer Treatment The fight against lung cancer continues to evolve, showcasing promising advancements that bring new hope to patients. Genprex, Inc. is at the forefront of this battle with its revolutionary gene therapy known as Reqorsa. This cutting-edge treatment has been developed specifically to target KRAS mutation in non-small cell lung...

Continue Reading
EfTEN United Property Fund Reports October Earnings and NAV

Updated Category News Views 192

Insights into EfTEN United Property Fund's Recent Performance EfTEN United Property Fund demonstrated a net profit of 110 thousand euros for October, totaling 2.214 million euros for the first ten months of the year, marking a significant improvement from 724 thousand euros during the same period last year. This impressive financial outcome led to a distribution to...

Continue Reading
Cardiff Oncology Reports Encouraging Results in mCRC Trial

Updated Category News Views 236

Cardiff Oncology Reveals Promising Clinical Trial Results Cardiff Oncology, Inc. (Nasdaq: CRDF), a pioneering clinical-stage biotechnology company, has recently announced encouraging results from its ongoing CRDF-004 clinical trial. This randomized Phase 2 trial is investigating the effects of onvansertib in patients suffering from first-line RAS-mutated metastatic...

Continue Reading
Japan's Growing Casting Polyurethane Market and Its Future

Updated Category News Views 127

Japan's Casting Polyurethane Market: A Rising Force The Japan casting polyurethane market is on the verge of significant transformation, anticipated to elevate from a valuation of US$ 134.74 million to a remarkable US$ 248.24 million by 2033. This growth trajectory highlights a compelling compound annual growth rate (CAGR) of 7.08%, revealing the underlying strength...

Continue Reading
Hudson Technologies Faces Challenges Amid Downgrade by B.Riley

Updated Category News Views 353

B.Riley Downgrades Hudson Technologies Stock In a recent market statement, B.Riley has lowered its outlook on Hudson Technologies (NASDAQ: HDSN), shifting the stock rating from Buy to Neutral. This adjustment comes amidst new growth projections adjusted downwards from +16.6% to +8.5%. The modification in expectations has been linked to ongoing pressures on...

Continue Reading